Document is current
Any future updates will be listed below
-
Authors
Mandeville, Ross
Sedghamiz, Hooman
Mansfield, Perry
Sheean, Geoffrey
Studer, Chris
Cordice, Derrick
Ghanbari, Ghodsieh
Malhotra, Atul
Nemati, Shamim
Koola, Jejo
-
Funding
Funding for this research was provided by:
Powell Mansfield Inc.
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 21 November 2024
First Online: 31 December 2024
Declarations
:
: This study was reviewed and approved by the Advarra Institutional Review Board (IRB), which is registered with the U.S. Office for Human Research Protections (OHRP) and the U.S. Food and Drug Administration (FDA) under IRB#00000971. The protocol for this study is identified as Pro00075951. All research activities were conducted in accordance with the ethical standards of the Advarra IRB and the applicable national and international guidelines for human subjects research. Informed consent was obtained from all participants included in the study in accordance with the protocol approved by the Advarra IRB (IRB#00000971, Protocol #Pro00075951).
: Informed consent to publish de-identified data was obtained from all participants included in the study, in accordance with the protocol approved by the Advarra IRB (IRB#00000971, Protocol #Pro00075951).
: CS, PM, HS, RM, GS, AM, SN: Receiving fees from Powell Mansfield, inc. CS, PM, RM, GS: Holding shares in Powell Mansfield, inc. Powell Mansfield, inc.: Holding patents relating to the content of the manuscript.
